Literature DB >> 32030405

Impact of Prehypertension on the Risk of Major Adverse Cardiovascular Events in a Chinese Rural Cohort.

Weili Duan1, Jiake Wu1, Sitong Liu2, Yundi Jiao1, Liqiang Zheng2, Yingxian Sun3, Zhaoqing Sun1.   

Abstract

BACKGROUND: The study was performed to investigate the impact of prehypertension defined by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7) on the risk of major adverse cardiovascular events (MACE) in a Chinese rural cohort.
METHODS: The epidemiological prospective cohort study included 38,765 participants aged ≥35 years followed for a median of 12.5 years-divided into normal BP (n = 7,366), prehypertension (n = 18,095), and hypertension groups (n = 13,304)-were enrolled for the final analysis. Follow-up for MACE including cardiovascular disease (CVD) death, stroke and myocardial infarction (MI) was conducted. Adjusted Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI).
RESULTS: The age and sex-adjusted incidence of MACE and its subtypes rose progressively with elevation of BP levels (P < 0.001). After adjusting multivariable Cox proportional hazards, significant increases were observed from the prehypertensive group for incident MACE (HR = 1.337, 95% CI: 1.186-1.508, P < 0.001), CVD mortality (HR = 1.331, 95% CI: 1.109-1.597, P = 0.002), and stroke (HR = 1.424, 95% CI:1.237-1.639, P < 0.001) but not MI (P > 0.05) compared with normal BP.
CONCLUSION: Prehypertensive individuals had a greater risk of incident MACE, CVD mortality, and stroke, implying that improvements in BP monitoring and early intervention in individuals with prehypertension in rural China are urgently needed. © American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; cohort study; hypertension; major adverse cardiovascular events; prehypertension

Year:  2020        PMID: 32030405     DOI: 10.1093/ajh/hpaa019

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  2 in total

1.  MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction.

Authors:  Shengjue Xiao; Tongneng Xue; Qinyuan Pan; Yue Hu; Qi Wu; Qiaozhi Liu; Xiaotong Wang; Ailin Liu; Jie Liu; Hong Zhu; Yufei Zhou; Defeng Pan
Journal:  Cardiovasc Ther       Date:  2021-10-25       Impact factor: 3.023

2.  Should elevated blood pressure be treated with antihypertensive drug therapy?

Authors:  Wilbert S Aronow
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-13       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.